These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34425232)

  • 21. Study of effect of variables on particle size of telmisartan nanosuspensions using box-Behnken design.
    Rao MR; Bajaj A
    Drug Res (Stuttg); 2014 Dec; 64(12):663-7. PubMed ID: 24549965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Active freeze drying for production of nanocrystal-based powder: A pilot study.
    Touzet A; Pfefferlé F; der Wel PV; Lamprecht A; Pellequer Y
    Int J Pharm; 2018 Jan; 536(1):222-230. PubMed ID: 29175644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is the amorphous fraction of a dried nanosuspension caused by milling or by drying? A case study with Naproxen and Cinnarizine.
    Kayaert P; Van den Mooter G
    Eur J Pharm Biopharm; 2012 Aug; 81(3):650-6. PubMed ID: 22579733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Itraconazole Nanosuspensions via Dual Centrifugation Media Milling: Impact of Formulation and Process Parameters on Particle Size and Solid-State Conversion as Well as Storage Stability.
    Willmann AC; Berkenfeld K; Faber T; Wachtel H; Boeck G; Wagner KG
    Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 35893783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fabrication of multicomponent amorphous bufadienolides nanosuspension with wet milling improves dissolution and stability.
    Zuo W; Qu W; Li N; Yu R; Hou Y; Liu Y; Gou G; Yang J
    Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1513-1522. PubMed ID: 28906144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fast dissolution of poorly water soluble drugs from fluidized bed coated nanocomposites: Impact of carrier size.
    Azad M; Moreno J; Bilgili E; Davé R
    Int J Pharm; 2016 Nov; 513(1-2):319-331. PubMed ID: 27639622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spray drying of API nanosuspensions: Importance of drying temperature, type and content of matrix former and particle size for successful formulation and process development.
    Czyz S; Wewers M; Finke JH; Kwade A; van Eerdenbrugh B; Juhnke M; Bunjes H
    Eur J Pharm Biopharm; 2020 Jul; 152():63-71. PubMed ID: 32376369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimization of formulation and process parameters for the production of nanosuspension by wet media milling technique: effect of Vitamin E TPGS and nanocrystal particle size on oral absorption.
    Ghosh I; Schenck D; Bose S; Ruegger C
    Eur J Pharm Sci; 2012 Nov; 47(4):718-28. PubMed ID: 22940548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rifampicin nanocrystals: Towards an innovative approach to treat tuberculosis.
    Melo KJC; Henostroza MAB; Löbenberg R; Bou-Chacra NA
    Mater Sci Eng C Mater Biol Appl; 2020 Jul; 112():110895. PubMed ID: 32409052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation of amorphous indomethacin nanoparticles by aqueous wet bead milling and in situ measurement of their increased saturation solubility.
    Colombo M; Minussi C; Orthmann S; Staufenbiel S; Bodmeier R
    Eur J Pharm Biopharm; 2018 Apr; 125():159-168. PubMed ID: 29371046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous production of drug nanoparticle suspensions via wet stirred media milling: a fresh look at the Rehbinder effect.
    Monteiro A; Afolabi A; Bilgili E
    Drug Dev Ind Pharm; 2013 Feb; 39(2):266-83. PubMed ID: 22503097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elaborating the crystal transformation referenced microhydrodynamic model and fracture mechanism combined molecular modelling of irbesartan nanosuspensions formation in wet media milling.
    Meng T; Li Y; Ma S; Zhang Q; Qiao F; Hou Y; Gao T; Yang J
    Int J Pharm; 2023 Feb; 632():122562. PubMed ID: 36586631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of Itraconazole Nanocrystal-Based Polymeric Film Formulations for Immediate Drug Release.
    Karagianni A; Peltonen L
    Pharmaceutics; 2020 Oct; 12(10):. PubMed ID: 33065968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets.
    Salazar J; Müller RH; Möschwitzer JP
    Eur J Pharm Sci; 2013 Jul; 49(4):565-77. PubMed ID: 23587645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of Top-down and Bottom-up Approaches by Using Design of Experiment (DoE) to Produce Meloxicam Nanocrystal Capsules.
    Liu T; Yu X; Yin H
    AAPS PharmSciTech; 2020 Jan; 21(3):79. PubMed ID: 31974817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced Solubility and Dissolution Rate of Lacidipine Nanosuspension: Formulation Via Antisolvent Sonoprecipitation Technique and Optimization Using Box-Behnken Design.
    Kassem MAA; ElMeshad AN; Fares AR
    AAPS PharmSciTech; 2017 May; 18(4):983-996. PubMed ID: 27506564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A microhydrodynamic rationale for selection of bead size in preparation of drug nanosuspensions via wet stirred media milling.
    Li M; Alvarez P; Bilgili E
    Int J Pharm; 2017 May; 524(1-2):178-192. PubMed ID: 28380391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and in vitro/in vivo evaluation of fenofibrate nanocrystals.
    Zuo B; Sun Y; Li H; Liu X; Zhai Y; Sun J; He Z
    Int J Pharm; 2013 Oct; 455(1-2):267-75. PubMed ID: 23876497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dermal flurbiprofen nanosuspensions: Optimization with design of experiment approach and in vitro evaluation.
    Oktay AN; Karakucuk A; Ilbasmis-Tamer S; Celebi N
    Eur J Pharm Sci; 2018 Sep; 122():254-263. PubMed ID: 29981401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design of self-dispersible dry nanosuspension through wet milling and spray freeze-drying for poorly water-soluble drugs.
    Niwa T; Danjo K
    Eur J Pharm Sci; 2013 Nov; 50(3-4):272-81. PubMed ID: 23907001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.